Last reviewed · How we verify
NCT02984059
Study Assessing Risk Factors for Abdominal Pain in Children With Inflammatory Bowel Disease
trial testing Genomic DNA in Inflammatory Bowel Disease in 126 participants. Completed in 1 August 2018.
1 August 2018
Quick facts
| Lead sponsor | Connecticut Children's Medical Center |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 126 |
| Start date | 21 October 2015 |
| Primary completion | 1 August 2018 |
| Estimated completion | 1 August 2018 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Genomic DNA
- RNA analysis
- Microbiome
- Calprotectin
- Pain questionnaires
- Anxiety/Depression Questionnaires
Conditions studied
- Inflammatory Bowel Disease — all drugs for Inflammatory Bowel Disease →
Sponsor
Connecticut Children's Medical Center
Who can join
Adults 8 to 18, any sex, with Inflammatory Bowel Disease. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
To characterize persistent abdominal pain in children with inflammatory bowel disease (IBD) by examining factors such as disease type, activity and location, psychosocial factors, and genetics. The investigators hypothesize that by using patient pain and psychological assessments in addition to analysis of blood, stool and colonic biopsies, we can better characterize factors that predispose children and adolescents with IBD to have persistent and/or disproportionate abdominal pain.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Characterizing Clinical Features and Creating a Gene Expression Profile Associated With Pain Burden in Children With Inflammatory Bowel Disease.
Grossi V, Hyams JS, Glidden NC, Knight BE, et al · · 2020 · cited 10× · PMID 31627210 · DOI 10.1093/ibd/izz240
Verify or expand the search:
- PubMed search for NCT02984059
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Inflammatory Bowel Disease
Currently open trials in the same condition.
- NCT07210580 — Testing the Impact of Measurement-Based Care on Quality of Life and Disease Management Among Veterans With Inflammatory · NA · recruiting
- NCT07242248 — A Study to Observe Real-world Evidence of Guselkumab Treatment in Participants With Ulcerative Colitis and Crohn's Disea · recruiting
- NCT07102368 — A Study to Generate Real-world Evidence of Guselkumab Effectiveness in Inflammatory Bowel Disease in Germany · recruiting
- NCT07252427 — Gut Microbiota in IBD With Comorbid Depressive Disorder · recruiting
- NCT06781827 — Research on the Use of Probiotics in the Prevention and Treatment of Inflammatory Bowel Disease · NA · recruiting
Other Connecticut Children's Medical Center trials
Trials by the same sponsor.
- NCT07224113 — Assessment and Educational Intervention to Reduce Ultra-processed Food Consumption in Pediatric Patients With IBD · recruiting
- NCT06843330 — Accuracy of Lactate Meter in GSDIa · recruiting
- NCT06982066 — Improving Communication Between AYA Oncology Patients and Clinicians: A Patient-Centered Intervention · NA · recruiting
- NCT06101264 — Application of Virtual Reality in Post-Operative Recovery of a Pediatric Scoliosis Patient Population · NA · completed
- NCT05874102 — The Effect of Body Position on Oropharyngeal Swallow Function in Infants · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT02984059 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Connecticut Children's Medical Center
- Last refreshed: 8 February 2019
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02984059.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing